1.
Ziegler CGK, Owings AH, Galeas-Pena M, et al. An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection. Microbiology spectrum. 2024:e0351623. doi:10.1128/spectrum.03516-23.
1.
Zaccaria M, Genovese L, Lawhorn BE, et al. Predicting potential SARS-CoV-2 mutations of concern via full quantum mechanical modelling. Journal of the Royal Society, Interface. 2024;21(211):20230614. doi:10.1098/rsif.2023.0614.
1.
Kim J, Choi YS, Lee YJ, et al. Limitations of the Cough Sound-Based COVID-19 Diagnosis Artificial Intelligence Model and its Future Direction: Longitudinal Observation Study. Journal of medical Internet research. 2024;26:e51640. doi:10.2196/51640.
1.
To T-L, Li X, Shu X. Spying on SARS-CoV-2 with Fluorescent Tags and Protease Reporters. Viruses. 2023;15(10). doi:10.3390/v15102005.
1.
Haltom J, Trovão NS, Guarnieri J, et al. SARS-CoV-2 Orphan Gene ORF10 Contributes to More Severe COVID-19 Disease. medRxiv : the preprint server for health sciences. 2023. doi:10.1101/2023.11.27.23298847.
1.
Wekking D, Senevirathne TH, Pearce JL, et al. The impact of COVID-19 on cancer patients. Cytokine & growth factor reviews. 2023. doi:10.1016/j.cytogfr.2023.11.004.
1.
Senevirathne TH, Wekking D, Swain JWR, Solinas C, De Silva P. COVID-19: From emerging variants to vaccination. Cytokine & growth factor reviews. 2023. doi:10.1016/j.cytogfr.2023.11.005.
1.
Weingarten-Gabbay S, Chen D-Y, Sarkizova S, et al. The HLA-II immunopeptidome of SARS-CoV-2. Cell reports. 2023;43(1):113596. doi:10.1016/j.celrep.2023.113596.
1.
Yurkovetskiy L, Egri S, Kurhade C, et al. S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.03.30.535005.
1.
Yurkovetskiy L, Egri S, Kurhade C, et al. S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness. bioRxiv : the preprint server for biology. 2023. doi:10.1101/2023.03.30.535005.